Source: centralcharts

Press Release: Misonix : BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration

DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc . (Nasdaq: MSON) ("Misonix"), today

Read full article »

Misonix's Competitors | Misonix's News | Misonix's Financials

Followers on Owler

253

Est. Annual Revenue

$25-100M

Est. Employees

1-25

President & CEO

Stavros G. Vizirgianakis

CEO Approval Rating

78/100

Misonix is a New York-based medical device company that designs, develops, manufactures, and markets invasive therapeutic ultrasonic equipment for tissue removal treatments.